Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Daniel LawRafael Salomão Romano and Samantha Salim of Daniel Law outline how the instructions will improve transparency and accountability in the Brazilian pharmaceutical patent scene -
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün of Gün and Partners discuss the recent court decision which helps clarify Article 86 of the Turkish IP Code
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Rajiv Suri of RNA, Technology and IP Attorneys outline how the Advertising Standards Council of India have reacted to increased online gaming trends during the COVID-19 pandemic
-
Sponsored by Maiwald Intellectual PropertyMarco Stief of Maiwald takes a closer look at the key elements of the scientific research initiative that succeeded the Horizon 2020 framework programme
-
Sponsored by IncoproColette Durst explains how she restructured the 3M team during COVID and why a pandemic is the perfect time to show IP worth
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Daleep Kumar of RNA, Technology and IP Attorneys explain how the Advertising Standards Council of India is acting to prevent misleading claims about coronavirus cures and remedies
